Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bedminster, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Intra-Cellular Therapies, Inc. has filed 1,007 SEC EDGAR filings since 08 Feb 2013

SEC filing history

Showing 651-675 of 1,000 matching filings.

Per page
25
Current page
27
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
02 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

FORM 8-K

Filing date
28 Sep 2017
Reporting date
27 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-213495

424B5

Filing date
28 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
26 Sep 2017
Reporting date
26 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-213495

424B5

Filing date
26 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
07 Sep 2017
Reporting date
07 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87380

SC 13G

Filing date
23 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
23 Aug 2017
Reporting date
23 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
09 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
28 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36274

8-K

Filing date
10 May 2017
Reporting date
10 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .